Navigation Links
Ceramide can target and kill cancer cells,,

Research by the scientists from Penn State College of Medicine brought to light that injecting ceramide// into the blood stream it is possible to target and kill breast cancer cells.

Ceramide is a natural substance that accumulates in the cancer cells and thus may be used to get better results out of breast cancer treatments. Researchers had used their techniques on mice for successful results.

However injecting ceramide in the usual way into the blood stream can have severe toxic results. Scientists, to overcome this, have used nanotechnology to create capsules of ceramides called liposomes. Such a way makes it easy for the capsules to move in the blood stream and release the ceramides in the tumor cells. This happens as ceramides are, by nature still unknown to scientists, attracted to tumor cells.

The liposome-encased ceramides reaches the tumor cells via the bloodstream. Then it enters the tumor cells through the vasculature, and disrupts the mitochondria of the cells. In mice these bundles of ceramide targets and destroys only breast cancer cells, leaving the surrounding cells healthy and functional.

The results of the study came up in the new issue of the journal Clinical Cancer Research.

Reference: Penn State University, Press Release, May 2005
'"/>




Page: 1

Related medicine news :

1. Ceramide Directs Stem Cells in Embryo
2. Feeding channel created by malaria parasite - a new target for malaria treatments
3. Enzyme may be target for obesity drugs
4. Scios Inc. targets drug giants in arthritis war
5. Pharmaceutical companies are targeting patients
6. New target for antidiabetic agents identified
7. Multi targeted approach required for suicide prevention in adolescents
8. GPs discontented with 48-hour target
9. Maori diabetes project way off target
10. Microcapsules target cancer cells
11. Indian American Scientist at Work on Multi-targeted Drug
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda ... orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including ... accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. ...
(Date:6/24/2016)... NY (PRWEB) , ... June 24, 2016 , ... ... Haute Living, is proud to recognize Dr. Barry M. Weintraub as a prominent ... “the most beautiful women in the world, and the most handsome men, look ...
(Date:6/24/2016)... MD (PRWEB) , ... June 24, 2016 , ... ... protocols for human induced pluripotent stem (iPS) cells and other difficult to transfect ... G9™ Cloning Medium. The PluriQ™ G9™ Gene Editing System is a ...
(Date:6/24/2016)... ... June 24, 2016 , ... Today, InhaleLabs.com ... ingestion of their medication by matching users with high quality water pipes within an ... with no commitment. , Inhale was founded by two brothers, Nick and Mike Hunter, ...
(Date:6/23/2016)... ... June 23, 2016 , ... vcfo, a consulting ... is pleased to announce the promotion of Mike Mackey to Regional Vice President ... where he was responsible for managing client projects and overseeing vcfo financial consultants ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Global MEMS Devices Medical Market Analysis 2016 - Forecast to ... The report contains up to date financial ... reliable analysis. Assessment of major trends with potential impact on ... dive analysis of market segmentation which comprises of sub markets, ...
(Date:6/23/2016)... June 23, 2016 Bracket , a leading ... next generation clinical outcomes platform, Bracket eCOA (SM) 6.0, ... June 26 – 30, 2016 in Philadelphia ... Clinical Outcome Assessment product of its kind to fully integrate ... Bracket eCOA 6.0 is a flexible platform for electronic ...
(Date:6/23/2016)... June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations ... Latin America . ... ... ... ...
Breaking Medicine Technology: